To determine whether the observed inhibition of choriocarcinoma cell invasion in vitro by TrkB inhibitors could be extended into antitumor activity in vivo, K252a was administrated to athymic nude mice with tumor xenografts of JAR cells. The gene discussed is NTRK2; the disease is neoplasm.